Gujarat Terce Laboratories Ltd Quarterly Results
Q2 FY21-22 Results Summary
Revenue
The revenue stands at ₹10.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.91 per cent from ₹9.94 crore. This corresponds to a year-on-year *(YoY) growth of 8.46 per cent.
Operating Profit
Operating Profit stands at ₹0.54 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 66.87 per cent from ₹1.63 crore. This corresponds to a year-on-year *(YoY) growth of 208.00 per cent.
PBDT
PBDT stands at ₹0.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 69.70 per cent from ₹1.65 crore. This corresponds to a year-on-year *(YoY) growth of 247.06 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.88 per cent from ₹1.60 crore. This corresponds to a year-on-year *(YoY) growth of 209.76 per cent.
Net Profit
Net Profit stands at ₹0.45 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.88 per cent from ₹1.60 crore. This represents a 178.95 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gujarat Terce Laboratories Ltd Earnings
- YOY
- QOQ
Gujarat Terce Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gujarat Terce Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gujarat Terce Laboratories Ltd Financial Reports
Gujarat Terce Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Guj. Terce Labs. | -1.02% | 0.00% | -3.49% | -9.47% | -20.00% | -37.35% |
| Chandra Bhagat | 1.13% | 0.00% | 33.30% | 26.55% | -0.02% | -24.16% |
| Deep Health AI | -0.94% | -2.78% | -10.64% | -24.73% | -72.62% | -51.39% |
| Remedium Life | -3.03% | -8.57% | -23.81% | -25.58% | -65.22% | -74.40% |
| Medico Intercon. | 4.40% | 11.40% | 13.48% | -21.00% | -14.79% | -36.65% |
| Pentokey Organy | 2.33% | 3.58% | -0.48% | 22.34% | -20.20% | -6.90% |
| Zenlabs Ethica | 0.00% | 1.51% | 28.34% | 69.41% | 53.91% | 12.09% |
Company Info
Company Information
Whole-time Director : Amrutbhai P Prajapati
Independent Director : Chhayaben Ashwinbhai Shah
Independent Director : Viplav Suryakantbhai Khamar
Managing Director & Chief Executive Officer : Aalap Prajapati
Independent Director : Surendra Kumar Sharma
Chairman & Wholetime Director : Natwarbhai P Prajapati
Independent Director : Avani Vishnubhai Patel
Company Sec. & Compli. Officer : Ripalben Sachinkumar Sukhadiya